Christine Nash

Christine Nash

Director/Board Member at RALLYBIO CORPORATION

Net worth: - $ as of 29/04/2024

51 year
Health Technology
Consumer Services
Commercial Services

Profile

Christine A.
Nash
is currently the Director at Rallybio Corp.
She previously worked as the Chairman at CM Group, Marketing Director at CoTherix, Inc., Principal at Eli Lilly & Co. and Genesoft Pharmaceuticals, Inc., VP-Strategic Marketing & Business Development at Hyperion Therapeutics, Inc. from 2010 to 2012, and Principal at Oncology Therapeutics Network Corp., Imana, Inc., and Chatiemac Consulting LLC.
She completed her undergraduate degree and MBA from Stanford University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/03/2024 0 ( -.--% ) - $ 29/04/2024

Christine Nash active positions

CompaniesPositionStart
RALLYBIO CORPORATION Director/Board Member 03/04/2022
All active positions of Christine Nash

Former positions of Christine Nash

CompaniesPositionEnd
Chatiemac Consulting LLC Corporate Officer/Principal -
Imana, Inc. Corporate Officer/Principal -
Chairman -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Christine Nash's experience

Training of Christine Nash

Stanford University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christine Nash's experience

Connections

22

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ELI LILLY AND COMPANY

Health Technology

RALLYBIO CORPORATION

Health Technology

Private companies7

Health Technology

Health Technology

Genesoft Pharmaceuticals, Inc.

Commercial Services

Distribution Services

Imana, Inc.

Technology Services

Chatiemac Consulting LLC

See company connections
  1. Stock Market
  2. Insiders
  3. Christine Nash